Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V van Pesch

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|August 22, 2014
Susac-like syndrome in a chronic cocaine abuser: could levamisole play a role?P Hantson, V Di Fazio, M Del Mar Ramirez Fernandez, et al.
Acta Neurologica Belgica|April 10, 2017
Corticosteroids in the management of acute multiple sclerosis exacerbationsI Smets, L Van Deun, C Bohyn, et al.
Acta Neurologica Belgica|February 28, 2007
Clinical, electrophysiological and brain imaging features during recurrent ictal cortical blindness associated with chronic liver failureV van Pesch, D Hernalsteen, K van Rijckevorsel, et al.
International Journal of Pharmaceutics|May 18, 2024
The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal administrationY Labrak, M Alhouayek, A Mwema, et al.
Clinical Rheumatology|September 1, 1999
Clinical significance of antiproteinase 3 antibody positivity in cANCA-positive patientsV van Pesch, M Jadoul, C Lefèbvre, et al.
European Journal of Neurology|December 27, 2015
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression indexL de Bock, J Fraussen, L M Villar, et al.
Clinical Immunology (Orlando, Fla.)|May 17, 2017
Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patientsL Le Berre, J Rousse, P-A Gourraud, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
Neurology|December 2, 2009
A consensus protocol for the standardization of cerebrospinal fluid collection and biobankingC E Teunissen, A Petzold, J L Bennett, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 2010
Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'C E Teunissen, H T Tumani, J L Bennett, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology|August 22, 2014
Susac-like syndrome in a chronic cocaine abuser: could levamisole play a role?P Hantson, V Di Fazio, M Del Mar Ramirez Fernandez, et al.
Acta Neurologica Belgica|April 10, 2017
Corticosteroids in the management of acute multiple sclerosis exacerbationsI Smets, L Van Deun, C Bohyn, et al.
Acta Neurologica Belgica|February 28, 2007
Clinical, electrophysiological and brain imaging features during recurrent ictal cortical blindness associated with chronic liver failureV van Pesch, D Hernalsteen, K van Rijckevorsel, et al.
International Journal of Pharmaceutics|May 18, 2024
The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal administrationY Labrak, M Alhouayek, A Mwema, et al.
Clinical Rheumatology|September 1, 1999
Clinical significance of antiproteinase 3 antibody positivity in cANCA-positive patientsV van Pesch, M Jadoul, C Lefèbvre, et al.
European Journal of Neurology|December 27, 2015
Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression indexL de Bock, J Fraussen, L M Villar, et al.
Clinical Immunology (Orlando, Fla.)|May 17, 2017
Decrease of blood anti-α1,3 Galactose Abs levels in multiple sclerosis (MS) and clinically isolated syndrome (CIS) patientsL Le Berre, J Rousse, P-A Gourraud, et al.
European Journal of Neurology|October 10, 2018
Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort studyJ Lorscheider, J Kuhle, G Izquierdo, et al.
Neurology|December 2, 2009
A consensus protocol for the standardization of cerebrospinal fluid collection and biobankingC E Teunissen, A Petzold, J L Bennett, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 1, 2010
Short commentary on 'a consensus protocol for the standardization of cerebrospinal fluid collection and biobanking'C E Teunissen, H T Tumani, J L Bennett, et al.
Pageof 3